We are excited to share that Seattle Children’s is now enrolling for the first chimeric antigen receptor (CAR) T-cell clinical trial in the U.S. for children with systemic lupus erythematosus (SLE). The clinical trial, known as REACT-01 is led by @SCTherapeutics, a novel nonprofit therapeutics development enterprise devoted to envisioning and testing next-generation cell and gene therapies for pediatric diseases. Learn more #CARTcell https://t.co/cAMB81tc40
Interesting case on #Infantbotulism ! Thread..
#EMORYACPNP2024
@DrTerryPedsNP @brownam130
That head lag is impressive! Infantile botulism in the NICU: a case report
https://t.co/jbPmAGPlQP
It typically affects children > 12 mo old
There are many types of C. botulinum: subtypes A and B cause IB.
IB is a gram + bacillus that produces spores and is found in the environment like in soil and aquatic sediment
IB can also be caused by contaminated honey!
5/
Did you know that there isn't a gold standard to test for DIC in pediatric patients?
I learned that there is a gold standard in adult patients, but more research is still needed in pediatrics to best determine DIC.
#DIC#EmoryACPNP2024
Don't fear! It can be treated with intravenous botulism immunoglobulin aka BIG-IV or BabyBIG!
It is currently recommended that if IB is suspected, don't wait for fecal samples or for diagnosis to be confirmed! This is to reduce morbidity and mortality!
6/6